-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2024.
- Northwest Biotherapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.26M shares, a 10.9% increase year-over-year.
- Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.12M shares, a 10.2% increase from 2022.
- Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.02M shares, a 0.79% increase from 2021.
- Northwest Biotherapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.01M shares, a 39% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)